Publications by authors named "O Mundler"
Background: A surveillance program was performed in colorectal cancer (CRC) patients after surgery, to diagnose asymptomatic recurrence.
Aims: To assess whether 18-FDG positron emission tomography/CT (PET/CT) improved the detection of recurrence during a 3-year follow-up.
Methods: A multicentre, two-arm randomised prospective trial comparing different 36-month follow-up strategies.
Background: Sorafenib is the recommended treatment for patients with advanced hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of selective internal radiotherapy (SIRT) with yttrium-90 (Y) resin microspheres in patients with hepatocellular carcinoma.
Methods: SARAH was a multicentre, open-label, randomised, controlled, investigator-initiated, phase 3 trial done at 25 centres specialising in liver diseases in France.
Sialadenitis is one of the common complications of radioiodine treatment for thyroid malignancy. The aim of this study was to evaluate the prevalence of radioiodine-induced sialadenitis and other side effects by using a self-administered questionnaire. From 1 January 2011 to 31 December 2012 all consecutive patients with a newly-established diagnosis of thyroid cancer who were treated with adjuvant radioiodine at La Timone University Hospital were sent a self-administered questionnaire on salivary complaints that had been specifically designed for this study.
View Article and Find Full Text PDFArticle Synopsis
- Q fever diagnosis is often challenging due to its reliance on serological tests, but F-FDG PET/CT offers a promising way to identify persistent infections of Coxiella burnetii.
- In a study of 167 patients who underwent F-FDG PET/CT from 2009 to 2015, 59% showed a hypermetabolic focus, leading to revised diagnoses for 63% of those tested.
- The study noted various infection sites, including valvular, vascular, osteoarticular, and lymphadenitis, confirming F-FDG PET/CT as a valuable diagnostic tool and suggesting new diagnostic criteria for persistent infections.